E-cig regulation issues are ‘not black and white’, says FDA’s Zeller

Mitch Zeller, director of the Food and Drug Administration’s Center for Tobacco Products, gave a keynote address at an e-cigarette conference at New York University’s School of Law on Friday. The long-time tobacco hawk struck a surprisingly conciliatory tone, acknowledging that the issue of how to regulate e-cigs, “is not black-and-white,” and that there’s currently “a stalemate” on harm reduction strategies. Zeller also mentioned the Nasem Report, which reported reduced short-term negative health outcomes from e-cigs and that vape users are less likely to smoke cigarettes.
Read full article
I'm already a subscriber
Author default picture

ECigIntelligence

This article was written by one of ECigIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual vaping markets. For a full list, please see our Who We Are page.

Our Key Benefits

The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization